AJL MEDICAL LIMITED
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (79/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-07-31 | 2024-07-31 |
|---|---|---|
| Average employees | 2 | 200 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
- • 1 accounts
- • 1 accounts
Corporate timeline (10 events)Click to expand
- 2026-06-17📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-05-19📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-05-09📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2024-07-10📄change-person-director-company-with-change-dateofficers · CH01
- 2024-07-10📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2024-03-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-08-01✏️certificate-change-of-name-companychange-of-name · CERTNM
- 2022-07-29🏢Company incorporatedAs AJL MEDICAL LIMITED
- 2022-07-29➕LINDNER, Anne Jutta, Dr appointeddirector
- 2022-07-29📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Anne Jutta Lindner Individual · British,German · DOB 10/1984 · age 42 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 29/07/2022 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · W postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AFTERSURG LTD→ 15610801 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AGE UK KENSINGTON AND CHELSEA→ 03926026 · est 2000 · no financials extracted | — | — | — | — | 26y | — | — |
| AIBO PLATFORM LTD→ 15931224 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AJIKE HEALTH LTD→ 14666635 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| AKNB CARE LTD→ 16921934 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AL BETOOL LIMITED→ 13994356 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AL IKHLAS GROUP CIC→ 17039106 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ALAN LEWIS & ASSOCIATES LIMITED→ 06545244 · est 2008 · no financials extracted | — | — | — | — | 18y | — | — |
| ALAQQAD HEALTHCARE LTD→ 17112960 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ALBION PARTNERS LIMITED→ 16466237 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ALCHEMHER CIC→ 16855423 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ALCOVE AESTHETICS LTD→ 16053063 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.